Sign in
4/A

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-17-026845

Chairman sold 40,000 shares at an average $40.37 ($1,614,800)

  • Chairman acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-13 Exercise or conversion : show line 1 in the form +20,000 $22.03 $440,600 1,550,216 D
2017-11-13 Sale : show line 2 in the form −20,000 $40.69 $813,800 1,530,216 D
2017-11-14 Exercise or conversion : show line 3 in the form +20,000 $22.03 $440,600 1,550,216 D
2017-11-14 Sale : show line 4 in the form −20,000 $40.05 $801,000 1,530,216 D
Open-market sales · 40,000 sh · avg $40.37 · $1,614,800

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-13 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −20,000 67,983 D
2017-11-14 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −20,000 47,983 D
Loading xslF345X03/doc4a.xml…